Context
Recently, new scientific research has clarified a long-standing mystery regarding why specific genetic mutations lead to debilitating nerve diseases while other, seemingly more severe mutations, do not. By utilizing yeast models to simulate human genetic behavior, researchers discovered that certain faulty proteins possess a “dominant-negative” property. This means the mutated protein does not simply disappear; it actively interferes with the healthy version, causing a critical shortage of the components needed for protein synthesis. This discovery is significant for the medical field as it identifies a specific target for future gene-silencing therapies.
1. What is Peripheral Neuropathy?
Peripheral neuropathy refers to a condition where the peripheral nerves—the vast communications network that transmits signals between the central nervous system (brain and spinal cord) and all other parts of the body—are damaged.
- Symptoms: High foot arches, curled toes, muscle wasting (thin calves), loss of sensation, and coordination issues.
- Prevalence: Inherited versions (IPN) affect approximately 1 in 2,500 individuals.
2. The Role of Aminoacyl-tRNA Synthetases (ARS)
ARS are essential enzymes dubbed “housekeeping” enzymes because they are critical for the very first step of protein synthesis in every cell.
- Function: They are responsible for “charging” tRNA. They attach specific amino acids (like alanine or asparagine) to their corresponding tRNA molecules.
- The Process:
- DNA is copied into mRNA.
- ARS enzymes ensure the correct amino acid is loaded onto the tRNA.
- tRNA delivers these amino acids to the ribosome (the protein factory) to build a polypeptide chain.
- Genetic Count: Humans have 37 genes coding for ARS enzymes; mutations in at least 7 of these are known to cause IPN.
3. The “Dominant-Negative” Phenomenon
The core question of the research was why some people with a “null” mutation (one gene copy completely missing) remain healthy, while those with a specific “missense” mutation become ill.
- Normal State: Humans have two copies of every gene. One functional copy is usually enough to maintain health.
- Dominant-Negative Property: In certain mutations, the faulty protein produced by the mutated gene does not just “stop working.” Instead, it actively interferes with the healthy protein produced by the normal gene copy.
- Dimerization: These proteins often work in pairs (dimers). A mutant protein can pair with a healthy one to create a “broken duo,” effectively reducing the total pool of functional enzymes to levels far below 50%, leading to cellular failure.
4. Why are Long Nerves Sensitive?
- Peripheral nerves are unique because of their extreme length (e.g., from the spine to the toe). The cell body must supply proteins to the very end of the axon. Even a slight decrease in the efficiency of protein synthesis due to these “dominant-negative” mutations can cause these long-distance supply lines to fail, leading to nerve degeneration.
Q1. With reference to Aminoacyl-tRNA synthetases (ARS), consider the following statements:
1. These enzymes are primarily responsible for the transcription of DNA into messenger RNA (mRNA).
2. Mutations in ARS genes are a known cause of inherited peripheral neuropathies.
3. A "dominant-negative" mutation refers to a condition where a faulty protein actively prevents a normal protein from functioning correctly.
Which of the statements given above are correct?
A) 1 and 2 only
B) 2 and 3 only
C) 1 and 3 only
D) 1, 2, and 3
Solution:
Answer: B
STATEMENT 1 IS INCORRECT: ARS enzymes are involved in translation, specifically the charging of tRNA with amino acids, not the transcription of DNA into mRNA (which is handled by RNA polymerase).
STATEMENT 2 IS CORRECT: As per recent medical research, mutations in several ARS genes (like GARS, YARS, etc.) are directly linked to inherited neuropathies like Charcot-Marie-Tooth disease.
STATEMENT 3 IS CORRECT: The "dominant-negative" effect describes a situation where the product of a mutant allele interferes with the function of the wild-type (normal) gene product, often by forming non-functional complexes.
